Multivariate meta-analysis of multiple correlated outcomes: development and application of methods, with empirical investigation of clinical impact
Multivariate meta-analysis of multiple correlated outcomes: development and application of methods, with empirical investigation of clinical impact
批准号:
MR/J013595/2
负责人:
Richard Riley
金额:
$26.64万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
'Meta-analysis' is the statistical approach for combining results from multiple studies examining the same clinical question, such as whether a treatment is effective or not. The aim of a meta-analysis is to combine the results from all studies, to produce an overall summary of the findings (e.g. whether the treatment is effective) which helps doctors and healthcare professionals make patient-related decisions based on all the evidence available. Reliable data to be combined in a meta-analysis are expensive and hard to come by; for example, they often come from clinical trials that have recruited hundreds of patients and followed them up for several years. It is thus important that when researchers undertake a meta-analysis they use all the available data in the most efficient way, to get the most of it. Yet, unfortunately in current practice most researchers are ignoring valuable information that is contained in the available meta-analysis data. This is because many healthcare studies have more than outcome of interest, such as time to recurrence of disease (called 'disease-free survival') and time to death (called 'overall survival'), and researchers currently meta-analyse each outcome separately. However, such multiple outcomes are often related to each other, i.e. they are correlated. For example, a patient's time to recurrence of disease is generally associated with their time of death, as when disease returns the time to death will often follow shortly after. So disease-free survival and overall survival results are correlated, but by meta-analysing each outcome independently, researcher ignores this correlation and thus lose potentially valuable information. In particular, if a study reports overall survival results, but not disease-free survival results, this study can still provide information about disease-free survival by recognising the correlation this outcome has with the available overall survival information. Yet at the moment most researchers simply 'throw away' this study when meta-analysing the disease-free survival results, and thus waste available data.We believe that a better approach is to meta-analyse correlated outcomes together and utilise their correlated information to get the most out of the available data. The way to do this is a 'multivariate meta-analysis', which is a statistical approach for meta-analysing all the outcomes simultaneously whilst recognising and accounting for their correlation. This allows meta-analysis results for, say, outcome A to be informed by evidence from studies reporting outcome A and also from studies reporting other correlated outcomes B, C and D. As this approach uses more of the information available, it can potentially lead to more reliable results for doctors and healthcare professionals.Our proposed research project aims to facilitate, and encourage more widespread use of, multivariate meta-analysis in current practice. We will firstly perform an empirical investigation as to how the use of multivariate meta-analysis would change existing clinical conclusions with Reviews of the Cochrane Pregnancy and Childbirth Group, to promote why the approach is important and to update clinical conclusions for pregnancy and childbirth based on more information. We will then develop statistical measures that 'flag' when multivariate meta-analysis is beneficial, so to directly inform researchers when they should use the multivariate approach. We will then develop and extend methods to estimating the correlation between outcomes, which are needed to apply the multivariate approach but are often missing. Finally, we will develop multivariate methods for meta-analysing multiple adverse outcomes. Current methods deal with more common outcomes, but adverse outcomes are rare and so more appropriate methods are needed for such situations. We will also produce a multivariate meta-analysis website, suitable statistical software, and a training course for researchers.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/jrsm.1129
发表时间:
2015-06
期刊:
Research synthesis methods
影响因子:
9.8
作者:
[Riley RD, Price MJ, Jackson D, Wardle M, Gueyffier F, Wang J, Staessen JA, White IR]
通讯作者:
White IR
DOI:
10.1093/biostatistics/kxu030
发表时间:
2015-01
期刊:
Biostatistics (Oxford, England)
影响因子:
--
作者:
[Efthimiou O, Mavridis D, Riley RD, Cipriani A, Salanti G]
通讯作者:
Salanti G
DOI:
10.1002/sim.6776
发表时间:
2016-03-30
期刊:
Statistics in medicine
影响因子:
2
作者:
[Bujkiewicz S, Thompson JR, Riley RD, Abrams KR]
通讯作者:
Abrams KR
DOI:
10.1002/jrsm.1276
发表时间:
2018-03
期刊:
Research synthesis methods
影响因子:
9.8
作者:
[Ensor J, Deeks JJ, Martin EC, Riley RD]
通讯作者:
Riley RD
DOI:
10.1177/0962280216631361
发表时间:
2018-03
期刊:
Statistical methods in medical research
影响因子:
2.3
作者:
[Burke DL, Bujkiewicz S, Riley RD]
通讯作者:
Riley RD
共 9 条
Sample Size calculations for UPDATing clinical prediction models to Ensure their accuracy and fairness in practice (SS-UPDATE)
-
批准号:MR/Z503873/1
-
项目类别:Research Grant
-
资助金额:$66.77万
-
财政年份:2024
-
负责人:Richard Riley
-
依托单位:
Systematic Reviews and Meta-Analysis of Prognosis Studies (REVAMP): development of core methods, reporting guidelines and a methodology handbook
-
批准号:MR/V038168/2
-
项目类别:Research Grant
-
资助金额:$47.74万
-
财政年份:2023
-
负责人:Richard Riley
-
依托单位:
Systematic Reviews and Meta-Analysis of Prognosis Studies (REVAMP): development of core methods, reporting guidelines and a methodology handbook
-
批准号:MR/V038168/1
-
项目类别:Research Grant
-
资助金额:$60.85万
-
财政年份:2021
-
负责人:Richard Riley
-
依托单位:
Multivariate meta-analysis of multiple correlated outcomes: development and application of methods, with empirical investigation of clinical impact
-
批准号:MR/J013595/1
-
项目类别:Research Grant
-
资助金额:$43.46万
-
财政年份:2013
-
负责人:Richard Riley
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于Meta分析、数据挖掘和网络药理学探讨中成药治疗广泛性焦虑症的疗效、用药规律和机制
-
批准号:2025A01004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:仇志坤
-
依托单位:
Meta建模驱动下CRRT管路凝血预警模型构建及其应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈娅妮
-
依托单位:
乳腺癌CDK4/6抑制剂耐药新机制:ACAT2代谢物Meta2靶向调控YAP构象及活性促进其核转位的机制研究
-
批准号:82303834
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙茜
-
依托单位:
抗精神病药治疗精神分裂症的西方与中国临床研究证据:建立联合数据库及运用网状meta分析方法
-
批准号:--
-
项目类别:--
-
资助金额:100万元
-
批准年份:2021
-
负责人:李春波
-
依托单位:
我国主要粮食作物化肥减施增效技术适宜性评估研究
-
批准号:32102492
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:丁文成
-
依托单位:
基于多维网状Meta分析和WGCNA的复方苦参注射液干预胃癌LncRNA临床关联模型构建
-
批准号:82074284
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:吴嘉瑞
-
依托单位:
针刺疗法网状Meta分析报告质量评价及关键方法研究
-
批准号:82004203
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李秀霞
-
依托单位:
基于医院的上市后高风险医疗器械快速评估体系的循证构建
-
批准号:72074161
-
项目类别:面上项目
-
资助金额:48.0万元
-
批准年份:2020
-
负责人:杜亮
-
依托单位:
校准2型糖尿病患者实际治疗效果的估计与应用: 临床试验适用性最大化研究
-
批准号:72074011
-
项目类别:面上项目
-
资助金额:48.0万元
-
批准年份:2020
-
负责人:孙凤
-
依托单位:
利用多个实验群体解析猪保幼带形成及其自然消褪的遗传机制
-
批准号:31972542
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2019
-
负责人:郭源梅
-
依托单位: